Pycnogenol and generic "pine bark extract" are chemically the same starting material — an extract of French maritime pine (Pinus pinaster) bark, rich in procyanidins. So a shopper reasonably assumes a cheaper generic is the same product at a lower price. The catch is that almost the entire human evidence base sits on the branded, patented version, which changes how much of that evidence a generic can actually claim. This is a case study in a trap that runs through the whole supplement aisle: branded-extract evidence.

What's actually the same

Both are maritime pine bark extracts, and both are standardized to procyanidin content in reputable products. If your interest is simply "a maritime pine bark polyphenol supplement," a well-made generic and the branded version are drawing from the same botanical and the same broad class of active compounds. Nothing here says a generic is fake or worthless.

What isn't the same: where the evidence lives

The human cognition and circulation trials on maritime pine bark are heavily concentrated in one branded extract — Pycnogenol, from Horphag Research — and, within that, largely one research group. The manufacturer's often-cited tally of dozens of trials reflects the volume of work on that specific patented preparation, not independent replication across the ingredient class. That matters for two reasons: a branded extract is manufactured to a controlled specification a generic may not match, and a body of evidence produced largely by parties tied to the product is weaker than the same number of independent studies would be. This is precisely why we grade maritime pine bark a C rather than higher.

  • The trials studied a specific patented extract with a controlled procyanidin specification — not "pine bark extract" as a generic category.
  • The evidence is concentrated in one manufacturer and largely one research group, so it does not automatically generalize to every product on the shelf.
  • A generic standardized to the same procyanidin percentage is a reasonable product — but it is borrowing the branded extract's evidence, not carrying its own.

How to read the label

  • If a benefit claim is what you're paying for, and it's based on the branded trials, then the branded extract is the only product those trials actually tested.
  • If you're buying a generic, look for a stated procyanidin standardization percentage — an unstandardized "pine bark extract" tells you the least.
  • Be skeptical of a generic that cites the branded extract's study results on its own label. Same plant does not mean same tested product.
  • Match the studied dose range (commonly 50–150 mg/day of a standardized extract) regardless of which you choose.

Safety notes that apply to both

Both forms are generally well tolerated, with occasional GI upset or dizziness. Because pine bark polyphenols can affect platelet function and immune signalling, people on blood thinners or immune-modulating medication should review it with a clinician first, and pregnant or breastfeeding people should use it only with guidance.

The bottom line

Pycnogenol and generic pine bark are the same botanical, but not the same evidence. The human trials tested a specific patented extract, largely from one source — so a generic standardized to the same procyanidin content is a plausible, cheaper option, but it inherits the branded product's claims rather than proving its own. Buy on standardization and studied dose, treat the branded trials as evidence about the branded product, and keep the overall grade honest: C, because the evidence is concentrated, not independently replicated.